|
1
|
Kim PS, Read SW and Fauci AS: Therapy for
early COVID-19: A critical need. JAMA. 324:2149–2150.
2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Chow JH, Khanna AK, Kethireddy S, Yamane
D, Levine A, Jackson AM, McCurdy MT, Tabatabai A, Kumar G, Park P,
et al: Aspirin use is associated with decreased mechanical
ventilation, ICU admission, and in-hospital mortality in
hospitalized patients with COVID-19. Anesth Analg: Oct 21, 2020
(Epub ahead of print). doi: 10.1213/ANE.0000000000005292.
|
|
3
|
Haque S, Jawed A, Akhter N, Dar SA, Khan
F, Mandal RK, Areeshi MY, Lohani M and Wahid M: Acetylsalicylic
acid (Aspirin): A potent medicine for preventing COVID-19 deaths
caused by thrombosis and pulmonary embolism. Eur Rev Med Pharmacol
Sci. 24:9244–9245. 2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Mohamed-Hussein AA, Aly KM and Ibrahim MA:
Should aspirin be used for prophylaxis of COVID-19-induced
coagulopathy? Med Hypotheses. 144(109975)2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Pavoni V, Gianesello L, Pazzi M, Stera C,
Meconi T and Frigieri FC: Venous thromboembolism and bleeding in
critically ill COVID-19 patients treated with higher than standard
low molecular weight heparin doses and aspirin: A call to action.
Thromb Res. 196:313–317. 2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Kelleni MT: Early use of non-steroidal
anti-inflammatory drugs in COVID-19 might reverse pathogenesis,
prevent complications and improve clinical outcomes. Biomed
Pharmacother. 133(110982)2021.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Kutti Sridharan G, Kotagiri R,
Chandiramani VH, Mohan BP, Vegunta R, Vegunta R and Rokkam VR:
COVID-19 and avoiding Ibuprofen. How good is the evidence? Am J
Ther. 27:e400–e402. 2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Rinott E, Kozer E, Shapira Y, Bar-Haim A
and Youngster I: Ibuprofen use and clinical outcomes in COVID-19
patients. Clin Microbiol Infect. 26:1259.e5–1259.e7.
2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Lee SW, Ha EK, Yeniova AÖ, Moon SY, Kim
SY, Koh HY, Yang JM, Jeong SJ, Moon SJ, Cho JY, et al: Severe
clinical outcomes of COVID-19 associated with proton pump
inhibitors: A nationwide cohort study with propensity score
matching. Gut. 70:76–84. 2021.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Mather JF, Seip RL and McKay RG: Impact of
famotidine use on clinical outcomes of hospitalized patients with
COVID-19. Am J Gastroenterol. 115:1617–1623. 2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Zhou J, Wang X, Lee S, Wu WK, Cheung BM,
Zhang Q and Tse G: Proton pump inhibitor or famotidine use and
severe COVID-19 disease: A propensity score-matched territory-wide
study. Gut. 2020(323668)2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Atkins JL, Masoli JA, Delgado J, Pilling
LC, Kuo CL, Kuchel GA and Melzer D: Preexisting comorbidities
predicting COVID-19 and mortality in the UK Biobank community
cohort. J Gerontol A Biol Sci Med Sci. 75:2224–2230.
2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Zhu A, Salminen LE, Thompson PM and
Jahanshad N: The UK Biobank Data Parser: A tool with built in and
customizable filters for brain studies. Organization for Human
Brain Mapping Rome, Italy, June 9-13, 2019.
|
|
14
|
Cangiano B, Fatti LM, Danesi L, Gazzano G,
Croci M, Vitale G, Gilardini L, Bonadonna S, Chiodini I, Caparello
CF, et al: Mortality in an Italian nursing home during COVID-19
pandemic: Correlation with gender, age, ADL, vitamin D
supplementation, and limitations of the diagnostic tests. Aging
(Albany NY). 12:24522–24534. 2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Tan CW, Ho LP, Kalimuddin S, Cherng BP,
Teh YE, Thien SY, Wong HM, Tern PJ, Chandran M, Chay JW, et al:
Cohort study to evaluate the effect of vitamin D, magnesium, and
vitamin B12 in combination on progression to severe outcomes in
older patients with coronavirus (COVID-19). Nutrition.
79-80(111017)2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Yuan S, Wang R, Chan JF, Zhang AJ, Cheng
T, Chik KK, Ye ZW, Wang S, Lee AC, Jin L, et al: Metallodrug
ranitidine bismuth citrate suppresses SARS-CoV-2 replication and
relieves virus-associated pneumonia in Syrian hamsters. Nat
Microbiol. 5:1439–1448. 2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Umhau J: Casting sunlight on an epidemic:
Is vitamin D a critical host factor to prevent COVID-19? J Infect
Dis: Mar 25, 2020 (Epub ahead of print).
|
|
18
|
Rubin R: Sorting out whether vitamin D
deficiency raises COVID-19 risk. JAMA. 325:329–330. 2021.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Murai IH, Fernandes AL, Sales LP, Pinto
AJ, Goessler KF, Duran CS, Silva CR, Franco AS, Macedo MB, Dalmolin
HH, et al: Effect of a single high dose of vitamin D3 on hospital
length of stay in patients with moderate to severe COVID-19: A
Randomized Clinical Trial. JAMA: Feb 17, 2021. doi:
10.1001/jama.2020.26848.
|
|
20
|
De Flora S, Balansky R and La Maestra S:
Rationale for the use of N-acetylcysteine in both prevention
and adjuvant therapy of COVID-19. FASEB J. 34:13185–13193.
2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Khanji MY, Aung N, Chahal CA and Petersen
SE: COVID-19 and the UK Biobank-Opportunities and challenges for
research and collaboration with other large population studies.
Front Cardiovasc Med. 7(156)2020.PubMed/NCBI View Article : Google Scholar
|
